| Discipline | Oncology |
|---|---|
| Language | English |
| Publication details | |
| History | 2001–present |
| Publisher | BioMed Central |
| Impact factor | 3.4 (2023) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | BMC Cancer |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| CODEN | BCMACL |
| ISSN | 1471-2407 |
| LCCN | 2002243079 |
| OCLC no. | 45893944 |
| Links | |
BMC Cancer is a peer-reviewed open access medical journal that publishes original research on cancer and oncology. It was established in 2001 at a time when open access publishing was in its infancy, and is published by BioMed Central. It was one of the first journals to be open access and exclusively published online.
Abstracting and indexing
The journal is abstracted and indexed by PubMed, MEDLINE, CAS, EMBASE, Scopus, Current Contents, and CABI. According to the Journal Citation Reports, its 2-year impact factor was 3.4 in 2023.
References
- Chap, Christna; Patel, Jigisha (2011-11-30). "A decade of progress in cancer research". BMC Cancer. 11 (1): 498. doi:10.1186/1471-2407-11-498. ISSN 1471-2407. PMC 3276491. PMID 22128753.
- "Aims and scope". BioMed Central. Retrieved 16 October 2020.
- "About". BioMed Central. Retrieved 2 April 2022.